Muhammad Ansar, PhD and Binnaz Yalcin, PhD
University of Lausanne, Switzerland; Institut NeuroMyoGene, INSERM U1315, Lyon, France
$120,000
This project will test promising treatment approaches in a mouse model of Cohen Syndrome and identify measurable biological markers to show whether a therapy is working. These biomarkers are an important step toward preparing potential treatments for future clinical trials.